探索Babesia bigemina乳酸脱酶的新兴抑制剂:一个计算结构生物学视角
Safiye Merve Bostancioglu1, Ozal Mutlu2
1Department of Biology, Faculty of Science, Marmara University, Goztepe, 34722, Istanbul, Türkiye.
Parasitology research
|January 8, 2025
概括
研究人员确定了针对Babesia bigemina乳酸脱酶 (LDH) 的新型化合物,用于治疗牛乳病. 三种化合物 (C9,C16,C18) 显示出作为特定抑制剂的前景,为德克萨斯热病提供了潜在的新疗法.
科学领域:
- 寄生虫学的寄生虫学
- 生物化学 生化学
- 药物发现 药物发现 药物发现
背景情况:
- 牛乳病是由Babesia bigemina引起的,由于药物毒性和耐药性,它存在治疗挑战.
- 乳酸脱酶 (LDH) 是寄生虫代谢中的关键酶,也是潜在的药物标.
- 在Babesia bigemina LDH (BbigLDH) 活性位点中的结构差异为宿主酶提供了选择性.
研究的目的:
- 通过基于结构的药物发现方法识别BbigLDH的新型选择性抑制剂.
- 评估潜在的抑制化合物的结合亲和力和稳定性.
- 探索牛乳病的新疗法策略.
主要方法:
- 针对BbigLDH.潜在药物候选者的虚拟查.
- 采用QM极化带对接和诱导适合对接来进行化合物过.
- 进行了分子动力学模拟和结合性自由能量计算.
主要成果:
- 确定了20种新型化合物,它们对BbigLDH有很高的亲和力,对宿主LDH有很低的亲和力.
- 在1μs的模拟中,C9,C16和C18化合物表现出稳定的结合和与催化残留保持的相互作用.
- 计算了这些有前途的化合物的低结合性自由能量.
结论:
- 化合物C9,C16和C18是开发特定BbigLDH抑制剂的潜在候选者.
- 这些化合物可能为牛婴儿病提供更有效,更少的毒性治疗.
- 对这些LDH抑制剂的进一步研究可能会导致对寄生虫疾病的新疗法.
更多相关视频
05:55Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
6.7K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
350
相关概念视频
02:21Globular and Fibrous Proteins
Many proteins can be classified into two distinct subtypes - globular or fibrous. These two types differ in their shapes and solubilities.
Globular proteins are also known as spheroproteins and typically are approximately round in shape. They contain a mix of amino acid types and contain differing sequences in their primary structures. Globular proteins have many different functions, such as enzymes, cellular messengers, and molecular transporters. These roles often require the proteins to be...
Globular proteins are also known as spheroproteins and typically are approximately round in shape. They contain a mix of amino acid types and contain differing sequences in their primary structures. Globular proteins have many different functions, such as enzymes, cellular messengers, and molecular transporters. These roles often require the proteins to be...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...